No prior systemic treatment (One prior systemic treatment is allowed for metastatic melanoma patients. Excluded prior therapies include prior high dose aldesleukin, sorafenib and DTIC/TMZ.) [clinicaltrials_resource:19e66504e3ceb97d17b90daa6def949c]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
No prior systemic treatment (One prior systemic treatment is allowed for metastatic melanoma patients. Excluded prior therapies include prior high dose aldesleukin, sorafenib and DTIC/TMZ.) [clinicaltrials_resource:19e66504e3ceb97d17b90daa6def949c]
Bio2RDF identifier
19e66504e3ceb97d17b90daa6def949c
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:19e66504e3ceb97d17b90daa6def949c
identifier
clinicaltrials_resource:19e66504e3ceb97d17b90daa6def949c
title
No prior systemic treatment (O ...... sorafenib and DTIC/TMZ.)
@en
type
label
No prior systemic treatment (O ...... 66504e3ceb97d17b90daa6def949c]
@en